Peptide side effects
Every medication that does something can do something unwanted. These articles catalogue peptide side effects and those reported for GLP-1 medications — nausea, injection-site reactions, and the rarer things worth knowing about — plus what researchers report about how long effects last and what tends to help.
Honest side-effect information is a feature, not a liability: it's how you and your provider decide together whether a treatment fits. Where an effect has its own article — nausea, hair shedding, fatigue — you'll find the detail there.
5 articles on this topic
-

Does Tirzepatide Cause Hair Loss?
In the pivotal 72-week obesity trials, hair loss was reported by about 3%–7% of tirzepatide groups versus about 1% with placebo. Weight-loss-related telogen effluvium is the leading explanation, but a direct drug effect has not been ruled out.
-

BPC-157 Side Effects and the Evidence Gap
Fewer than 30 people have taken BPC-157 in a published human study. That number, more than any list of symptoms, is the honest answer to what its side effects are.
-

Sermorelin Side Effects, by the Numbers
About one patient in six gets a reaction where the needle went in. Almost everything else on the list occurs in under 1% — but the trial data behind those numbers comes from a population that may not look like you.
-

Tirzepatide Side Effects, From Common to Rare
Gastrointestinal effects are the ones almost everyone asks about — and across the tirzepatide dose range they affect 39% to 49% of people, concentrated in the weeks when the dose is going up.
-

Semaglutide Side Effects, From Common to Rare
Across pooled STEP-trial safety data, only 4.3% of adults taking semaglutide 2.4 mg stopped treatment because of gastrointestinal side effects.